La Jolla Pharmaceutical Company
LJPC
LJPC was delisted on the 19th of August, 2022.
29 hedge funds and large institutions have $72.1M invested in La Jolla Pharmaceutical Company in 2014 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 11 increasing their positions, 4 reducing their positions, and 5 closing their positions.
175% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 4
138% more capital invested
Capital invested by funds: $30.3M → $72.1M (+$41.7M)
120% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 5
26% more funds holding
Funds holding: 23 → 29 (+6)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
+$10.2M |
| 2 |
BC
Broadfin Capital
New York
|
+$7.16M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.22M |
| 4 |
VAM
Visium Asset Management
New York
|
+$5.72M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.16M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TAM
Tocqueville Asset Management
New York
|
-$259K |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$110K |
| 3 |
Citigroup
New York
|
-$103K |
| 4 |
TMC
Trellus Management Company
Delray Beach,
Florida
|
-$34.8K |
| 5 |
Barclays
London,
United Kingdom
|
-$32K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BAM
26
Brave Asset Management
Summit,
New Jersey
| $17K | – | – | – |
|
|
WA
27
WFG Advisors
Dallas,
Texas
| $4K | -$3.71K | -373 | -50% |
|
|
TRCT
28
Tower Research Capital (TRC)
New York
| $3K | +$2.77K | +278 | New |
|
|
GSC
29
Ground Swell Capital
Folly Beach,
South Carolina
| $1K | +$100 | +10 | +11% |
|
|
TAM
30
Tocqueville Asset Management
New York
| – | -$259K | -28,225 | Closed |
|
|
31
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$110K | -12,000 | Closed |
|
|
32
Citigroup
New York
| – | -$103K | -11,225 | Closed |
|
|
33
Barclays
London,
United Kingdom
| – | -$32K | -3,600 | Closed |
|
34
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$13K | -1,500 | Closed |
|
LJPC Hedge Fund Activity: Q3 2014 in Review
29 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in La Jolla Pharmaceutical Company (LJPC) for Q3 2014, worth a combined $72.1M — up 138% from $30.3M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new LJPC positions and 5 closed out — a net gain of 6 holders — while 11 added to existing stakes and 4 trimmed.
The largest buyer was Tang Capital Management, adding an estimated $10.2M. The largest seller was Tocqueville Asset Management, exiting entirely with an estimated $259K sold.
- 29 institutional investors held La Jolla Pharmaceutical Company (LJPC) as of Q3 2014, up from 23 in Q2 2014.
- Funds reported $72.1M of La Jolla Pharmaceutical Company stock for Q3 2014, up 138% quarter-over-quarter.
- 11 funds opened new La Jolla Pharmaceutical Company positions in Q3 2014 and 5 closed out, a net change of +6 holders.
- The largest La Jolla Pharmaceutical Company buyer in Q3 2014 was Tang Capital Management, an estimated $10.2M added.
- The largest La Jolla Pharmaceutical Company seller in Q3 2014 was Tocqueville Asset Management, an estimated $259K sold.
Based on aggregated 13F filings for Q3 2014.